HUP0302963A2 - Nagy tisztaságú szimvasztatint tartalmazó kompozíciók - Google Patents

Nagy tisztaságú szimvasztatint tartalmazó kompozíciók

Info

Publication number
HUP0302963A2
HUP0302963A2 HU0302963A HUP0302963A HUP0302963A2 HU P0302963 A2 HUP0302963 A2 HU P0302963A2 HU 0302963 A HU0302963 A HU 0302963A HU P0302963 A HUP0302963 A HU P0302963A HU P0302963 A2 HUP0302963 A2 HU P0302963A2
Authority
HU
Hungary
Prior art keywords
ighly
compositions
simvastatin
purified simvastatin
purified
Prior art date
Application number
HU0302963A
Other languages
English (en)
Inventor
Ferenc Kóródi
David Leonov
István Melczer
Csaba Szabó
Szabolcs Sályi
Original Assignee
Plus Chemicals, B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Plus Chemicals, B.V. filed Critical Plus Chemicals, B.V.
Publication of HUP0302963A2 publication Critical patent/HUP0302963A2/hu
Publication of HUP0302963A3 publication Critical patent/HUP0302963A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pyrane Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Jelen találmány tárgya olyan eljárásra vonatkozik, amely segítségévelfélszintetikus sztatinokat, az adott eljárás során képződőintermediereket és az eljárással készült nagy tisztaságúszimvasztatint lehet előállítani. A találmány nagy tisztaságúszimvasztatint tartalmazó gyógyszerkészítményekre is vonatkozik. Ó
HU0302963A 2000-07-27 2001-07-26 Ighly purified simvastatin compositions HUP0302963A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22111200P 2000-07-27 2000-07-27
PCT/US2001/023525 WO2002009697A1 (en) 2000-07-27 2001-07-26 Highly purified simvastatin compositions

Publications (2)

Publication Number Publication Date
HUP0302963A2 true HUP0302963A2 (hu) 2003-12-29
HUP0302963A3 HUP0302963A3 (en) 2004-03-01

Family

ID=22826406

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0302963A HUP0302963A3 (en) 2000-07-27 2001-07-26 Ighly purified simvastatin compositions

Country Status (20)

Country Link
US (1) US6686481B2 (hu)
EP (1) EP1303268A4 (hu)
JP (1) JP2004505045A (hu)
KR (1) KR100542094B1 (hu)
CN (1) CN1446088A (hu)
AU (2) AU8298101A (hu)
CA (1) CA2419206A1 (hu)
CZ (1) CZ2003554A3 (hu)
HR (1) HRP20030109A2 (hu)
HU (1) HUP0302963A3 (hu)
IL (1) IL154068A0 (hu)
IS (1) IS6698A (hu)
MX (1) MXPA03000748A (hu)
NZ (1) NZ524418A (hu)
PL (1) PL365691A1 (hu)
RU (1) RU2275909C2 (hu)
SK (1) SK2172003A3 (hu)
WO (1) WO2002009697A1 (hu)
YU (1) YU101402A (hu)
ZA (1) ZA200300344B (hu)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100435078B1 (ko) * 2002-02-08 2004-06-09 종근당바이오 주식회사 심바스타틴의 정제방법
KR100502834B1 (ko) * 2002-03-25 2005-07-20 보령제약 주식회사 개선된 락톤화 반응에 의한 심바스타틴의 제조방법 및이의 정제방법
KR20050098313A (ko) * 2003-02-11 2005-10-11 플러스 케미칼스 비.브이. 제어된 범위의 심바스타틴 이량체 함량을 갖는심바스타틴의 제조 방법
EP1563837A1 (en) * 2004-02-03 2005-08-17 Ferrer Internacional, S.A. Hypocholesterolemic compositions comprising a statin and an antiflatulent agent
ATE552825T1 (de) 2006-04-26 2012-04-15 Rosemont Pharmaceuticals Ltd Flüssige orale zusammensetzungen
WO2007125547A2 (en) 2006-05-03 2007-11-08 Manne Satyanarayana Reddy Novel process for statins and its pharmaceutically acceptable salts thereof
CA2652883C (en) * 2006-05-24 2016-01-05 The Regents Of The University Of California Methods and materials for making simvastatin and related compounds
US8404841B2 (en) 2006-10-09 2013-03-26 Msn Laboratories Limited Process for the preparation of statins and their pharmaceutically acceptable salts thereof
JP2009114121A (ja) * 2007-11-06 2009-05-28 Kaneka Corp シンバスタチンの製造方法
WO2010089770A2 (en) 2009-01-19 2010-08-12 Msn Laboratories Limited Improved process for the preparation of highly pure (3r,5s)-7-[2-cyclopropyl-4-(4-fluorophenyl) quinolin-3-yl]-3,5-dihydroxy-6(e)-heptenoic acid and pharmaceutically acceptable salts thereof
EP2526099B1 (en) 2010-01-18 2016-03-30 MSN Laboratories Limited Improved process for the preparation of amide intermediates and their use thereof
CN103864611B (zh) * 2013-12-24 2015-11-11 深圳华润九新药业有限公司 一种辛伐他汀羟基酸化物的制备方法、组合物、组合物的制备方法及其应用
CN103755562B (zh) * 2013-12-24 2015-11-18 深圳华润九新药业有限公司 一种洛伐他汀羟基酸化物的制备方法、组合物、组合物的制备方法及其应用
US10434106B2 (en) 2017-05-19 2019-10-08 Warsaw Orthopedic, Inc. Oxysterol-statin compounds for bone growth

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4293496A (en) 1980-02-04 1981-10-06 Merck & Co., Inc. 6(R)-[2-(8-Hydroxy-2,6-dimethylpolyhydronaphthyl-1)-ethyl]-4(R)-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-ones
US4444784A (en) 1980-08-05 1984-04-24 Merck & Co., Inc. Antihypercholesterolemic compounds
US4582915A (en) 1983-10-11 1986-04-15 Merck & Co., Inc. Process for C-methylation of 2-methylbutyrates
US4820850A (en) 1987-07-10 1989-04-11 Merck & Co., Inc. Process for α-C-alkylation of the 8-acyl group on mevinolin and analogs thereof
US5223415A (en) 1990-10-15 1993-06-29 Merck & Co., Inc. Biosynthetic production of 7-[1',2',6',7',8',8a'(R)-hexahydro-2'(S),6'(R)-dimethyl-8'(S)-hydroxy-1'(S)-naphthyl]-3(R),5(R)-dihydroxyheptanoic acid (triol acid)
US5159104A (en) 1991-05-01 1992-10-27 Merck & Co., Inc. Process to simvastatin ester
US5393893A (en) 1993-11-08 1995-02-28 Apotex, Inc. Process for producing simvastatin and analogs thereof
DK0971913T3 (da) * 1997-01-28 2003-08-04 Plus Chemicals Bv Fremgangsmåde til fremstillingen af semisyntetiske statiner via hidtil ukendte mellemprodukter
SI9800057A (sl) 1998-02-26 1999-08-31 Krka, Tovarna Zdravil, D.D. Postopek za pripravo simvastatina in njegovih derivatov
EP0940395A1 (en) 1998-03-05 1999-09-08 Synthon B.V. Process for producing simvastatin and/or its derivatives
NO991045L (no) * 1998-03-05 1999-09-06 Synthon Bv FremgangsmÕte ved fremstilling av simvastatin og/eller dets derivater

Also Published As

Publication number Publication date
HUP0302963A3 (en) 2004-03-01
IS6698A (is) 2003-01-24
HRP20030109A2 (en) 2005-02-28
ZA200300344B (en) 2004-01-21
EP1303268A1 (en) 2003-04-23
US20020115712A1 (en) 2002-08-22
KR20030047995A (ko) 2003-06-18
RU2275909C2 (ru) 2006-05-10
MXPA03000748A (es) 2004-06-25
NZ524418A (en) 2004-12-24
JP2004505045A (ja) 2004-02-19
WO2002009697A1 (en) 2002-02-07
YU101402A (sh) 2006-01-16
IL154068A0 (en) 2003-07-31
CN1446088A (zh) 2003-10-01
CZ2003554A3 (cs) 2003-08-13
SK2172003A3 (en) 2003-06-03
EP1303268A4 (en) 2006-08-09
US6686481B2 (en) 2004-02-03
AU8298101A (en) 2002-02-13
KR100542094B1 (ko) 2006-01-11
CA2419206A1 (en) 2002-02-07
AU2001282981B2 (en) 2004-08-05
PL365691A1 (en) 2005-01-10

Similar Documents

Publication Publication Date Title
HUP0302963A2 (hu) Nagy tisztaságú szimvasztatint tartalmazó kompozíciók
HUP0303996A2 (hu) Vakcinakészítmények
HUP0303143A2 (hu) A VII-es faktor és a IX-es faktor polipeptidek kombinált alkalmazása
HUP0300327A2 (hu) Percyquinnin, eljárás előállítására és gyógyászati alkalmazása
HUP0303354A2 (hu) Gyulladásgátló hatású 6-alfa, 9-alfa-difluor-17-alfa-(2-furanilkarbonil)oxi-11-béta-hidroxi-16-alfa-metil-3-oxo-androst-1,4-dién-17-tiokarbonsav-S-fluormetil-észter, eljárás az előállítására és ezt tartalmazó gyógyszerkészítmény
HUP9602685A2 (hu) Helyettesített kinolin-2-karbonsav-amidok, eljárás előállításukra és alkalmazásuk gyógyszerekként, valamint közbenső termékek
HUP0000527A2 (hu) Eljárás tolterodin előállítására és az intermedier
HUP0301802A2 (hu) Eljárás carvedilol elżállítására, kristályos carvedilol, eljárás elżállítására és a vegyületet tartalmazó gyógyszerkészítmény
HUP0003386A2 (hu) CRF antagonisták alkalmazása depresszió, kardiovaszkuláris betegségek kezelésére szolgáló gyógyszerkészítmények előállítására
HK1071129A1 (en) Novel compounds
MY134586A (en) Novel pyrroles derivatives as pharmaceutical agents
HUP0303854A2 (hu) Szintetikus erythropoiesis-stimuláló proteinek
MXPA04000755A (es) Nuevos compuestos.
SE0104340D0 (sv) New compounds
HUP0203521A2 (hu) Kristályos 4-karboxi-amino-2-etil-1,2,3,4-tetrahidro-kinolin CEPT inhibitor, eljárás az előállítására, ezt tartalmazó gyógyszerkészítmény és alkalmazása
HUT76829A (en) Semi-synthetic taxanes, process for producing them and pharmaceutical compositions containing them
HUP0204012A2 (hu) Eljárás statinvegyületek kinyerésére fermentléből
HUP0302798A2 (hu) Javított eljárások pantotenát előállítására
HUP0301991A2 (hu) IL-18-inhibitorok alkalmazása atheroszklerózis kezelésére és/vagy megelżzésére
HUP0001014A2 (hu) Gasztrointesztinális lipáz inhibitorok felhasználása
SE9903291D0 (sv) New process
HUP0402112A2 (hu) Eljárás kristályos imipenem előállítására
HUP0401014A2 (hu) Eljárás 7-amino-szin-3,5-dihidroxi-heptánsavszármazékok előállítására, 6-ciano-szin-3,5-dihidroxi-hexánsav származékokon keresztül
CA2190570A1 (en) Process for producing 3-amino-2-oxo-1-halogenopropane derivatives
HUP0401208A2 (hu) Valamely lipáz inhibitort és valamely szacharóz-zsírsav-észtert tartalmazó gyógyászati készítmény és eljárás az előállítására

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees